Tag Archives: NASDAQ:ZGNX

Zogenix (NASDAQ:ZGNX) Post Smaller Loss in Fiscal Q4; Ends Marketing Partnership – ZGNX, AGN, ENDP, ALKS

The SAN DIEGO, California based Zogenix, Inc (NASDAQ:ZGNX) announced on Friday that it had a smaller loss in fiscal Q4 after it finished a marketing partnership on its injectable migraine treatment, Sumavel DosePro.

Zogenix ended a marketing partnership with Japanese …

Posted in Healthcare, Latest Headlines | Tagged , , , , , , , , , , , | Comments Off

U.S. Stock Market Movers Overview: LinkedIn (NYSE:LNKD), DISH Network (NASDAQ:DISH) – LNKD, DISH, DIS, ZGNX, PAL, CBB

Investors responded positively to overall marker on Wednesday. Key movement were monitored in Zogenix, Inc (NASDAQ:ZGNX) and North American Palladium Ltd (USA) (NYSE:PAL) on percentage gainers side while Cincinnati Bell Inc (NYSE:CBB) was major percentage decliner.

LinkedIn Corp (NYSE:LNKD) stock …

Posted in Latest Headlines, Services | Tagged , , , , , , , , , , , , , , , , , | Comments Off

MAP Pharmaceuticals (NASDAQ:MAPP) Wins FDA Approval for Levadex; Stock Hikes – MAPP, AGN, PATH, ZGNX

The Mountain View, California based MAP Pharmaceuticals Inc’s (NASDAQ:MAPP) stock hiked on Friday after encouraging regulatory news on what could become the corporation’s primary approved product.

MAP reported that the United States Food and Drug Administration permitted the drug developer’s …

Posted in Healthcare, Latest Headlines | Tagged , , , , , , , , , , , | Comments Off

Soaring stocks and the reasons why (DNDN, JAZZ, ZGNX)

In this article: Dendreon Corporation (NASDAQ:DNDN), Jazz Pharmaceuticals (NASDAQ:JAZZ) and Zogenix (NASDAQ:ZGNX).

Dendreon Corporation (NASDAQ:DNDN) shares continued to climb today after the company announced yesterday that sales of its prostate-cancer therapy Provenge have continued to grow in the fourth quarter. …

Posted in Latest Headlines, Reports | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off